Pulse Infoframe Inc.

Our Founder & CEO Dr. Femida Gwadry-Sridhar has been invited to speak alongside other leaders of healthcare technology companies at a series of conferences being put on by the Canada-UK Chamber of Commerce at Canada House, One Nucleus and GIANT Health Event at the start of next month. Femida will serve as a panelist and speak on a variety of topics with the overarching theme of building knowledge by sharing knowledge through evidence generation. We will be sharing additional details about each speaking session in the coming weeks. You can learn more about these events below: https://lnkd.in/gEqV2Dsb - Canada-UK Chamber of Commerce https://lnkd.in/erk3WXa8 - Genesis Conference 2024 https://lnkd.in/e_SdaUjf - Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence https://www.giant.health/ - Giant Health   #GenesisLondon24 #CanadaUK #Giant2024 #Lifescience

CACNA1C-related disorders go beyond Timothy Syndrome, including developmental delay, intellectual disability, epilepsy, and psychiatric conditions, even without cardiac symptoms. In this film clip, Dr. Rebecca Levy from Stanford University School of Medicine, who is also a member of our Scientific Advisory Board, acknowledges the range of symptoms associated with CACNA1C variants. Have you watched the whole film? (link in the comments below). We have entered it into the Smiley Charity Film Awards, and we would greatly appreciate your vote to help us advance to the next stage of judging. #RareDiseases #Research #CACNA1C #TimothySyndrome #LongQT8 #CFA25 #CharityFilmAwards

Our Founder & CEO, Dr. Femida Gwadry-Sridhar, had an incredible experience speaking at the Startup Spotlight session during the GIANT Health Event. It was a great opportunity to highlight innovation and engage with brilliant minds shaping the future of healthcare. A big thank you to Giant Health for creating such a vibrant platform for collaboration and ideas! #GIANT2024 #RealWorldData

Among the exceptional One Nucleus #GenesisLondon2024 Fringe Events is "Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence (RWE)" hosted by J A Kemp. This discussion will delve into how RWE can enhance drug discovery, clinical trial innovation, and commercialisation with a focus on rare diseases as a model, offering insights applicable across the therapeutic landscape. Join an outstanding line-up of experts Tony Jones (One Nucleus), Ron (Roni) A. Jortner (Aspire Biosciences), Femida Gwadry-Sridhar (Pulse Infoframe Inc.), Ravi Srinivasan (J A Kemp) and Julie Adrian (FINN Partners) as they explore how effectively leveraging RWE can bring groundbreaking treatments to patients. Seats are limited—learn more and secure your spot here: https://lnkd.in/ePNaXY4c

It was a pleasure for our Founder & CEO Dr. Femida Gwadry-Sridhar to be part of a panel at the Canada-UK Chamber of Commerce Annual Health & Life Sciences Forum: Real-World Evidence & Big Data in Healthcare: a Canada-UK Discussion. Femida was joined by other industry experts to discuss "Risk, Regulations, and Rewards: Discussion on How and Where We Use Big Data." Thank you to the Canada-UK Chamber of Commerce for hosting another excellent event! #CanadaUK #MachineLearning #AI #LifeScience #BigData #RealWorldData

What’s driving the future of health-tech innovation? Find out at GIANT Health Event 2024, where Pulse Infoframe Founder and CEO, Dr. Femida Gwadry-Sridhar, will speak on the "Startup Spotlight" panel. In this dynamic session will showcase the importance of knowledge translation by leveraging real-world data to help accelerate the adoption of tech innovation in healthcare. Giant Health is the UK’s premier NHS innovation festival, featuring 6+ immersive shows, 100s of world-class speakers, and groundbreaking start-up pitches. It’s the go-to event for networking, learning, and celebrating the health-tech breakthroughs shaping tomorrow. Learn more about the event here: https://www.giant.health/ #GIANT2024 #HealthTech #DigitalHealth #NHS 

Among the exceptional One Nucleus #GenesisLondon2024 Fringe Events is "Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence (RWE)" hosted by J A Kemp. This discussion will delve into how RWE can enhance drug discovery, clinical trial innovation, and commercialisation with a focus on rare diseases as a model, offering insights applicable across the therapeutic landscape. Join an outstanding line-up of experts Tony Jones (One Nucleus), Ron (Roni) A. Jortner (Aspire Biosciences), Femida Gwadry-Sridhar (Pulse Infoframe Inc.), Ravi Srinivasan (J A Kemp) and Julie Adrian (Alverium Health) as they explore how effectively leveraging RWE can bring groundbreaking treatments to patients. Seats are limited—learn more and secure your spot here: https://lnkd.in/ePNaXY4c

How can we harness the power of Real-World Evidence (RWE) to transform clinical trials and rare disease treatments? Dr. Femida Gwadry-Sridhar, Founder and CEO of Pulse Infoframe, will be speaking at the Genesis Fringe Event: Discovery to Commercialization in Rare Diseases on "The Standardization of Data Collection and Sharing to Deliver Useful RWE to Inform Clinical Trial Design." She will share insights on tackling challenges in RWE standardization to enhance innovation and drive better outcomes for patients. This One Nucleus event explores how RWE can accelerate drug discovery, improve trial designs, and drive commercialization in rare diseases, offering lessons for the broader healthcare landscape. You can learn more about the event here: https://lnkd.in/e_SdaUjf #LifeScience #Genesis24 #OneNucleus #DrugDevelopment #Pharma #GenesisLondon24 

What’s in store for healthcare storytelling in 2025? Find out at Genesis 2024, where Pulse Infoframe Founder and CEO, Dr. Femida Gwadry-Sridhar, will moderate the panel "Watch this Space!" featuring top healthcare journalists. Together, they’ll dive into the trends, innovations, and narratives set to shape the future of healthcare. For over two decades, the Genesis conference by One Nucleus has united life science leaders to explore emerging trends, spark collaborations, and envision the future. This year’s theme, "Maximising Returns from Life Science Innovation," ensures impactful discussions and fresh perspectives. Learn more about the event here: https://lnkd.in/erk3WXa8 - Genesis 2024 #LifeSciences #Genesis24 #OneNucleus #DrugDevelopment #Pharma

Pulse Infoframe Founder and CEO, Dr. @Femida Gwadry-Sridhar, will be a featured panelist at the Canada-UK Chamber of Commerce Annual Health & Life Sciences Forum: Real-World Evidence & Big Data in Healthcare: a Canada-UK Discussion this December 3rd at Canada House in London. This half-day event brings together industry leaders to explore the transformative power of collaboration and innovation, focusing on AI & ML in healthcare, value-based care, investment opportunities, and privacy risks. Dr. Gwadry-Sridhar will share her insights during the panel discussion, "Risk, Regulations, and Rewards: Discussion on How and Where We Use Big Data." Learn more about the conference here: https://lnkd.in/gEqV2Dsb   #LifeScience #AI #HealthcareInnovation #RealWorldEvidence #pulseinfoframe #ShapingHealthData